111 related articles for article (PubMed ID: 8493457)
1. Parathyroid hormone and osteocalcin levels in plasma and ultrafiltrate during hemofiltration.
Weiss LG; Danielson BG; Jüppner H; Ljunghall S; Wide L
Scand J Urol Nephrol; 1993; 27(1):109-14. PubMed ID: 8493457
[TBL] [Abstract][Full Text] [Related]
2. Clinical aspects and applications of hemofiltration.
Weiss LG
Scand J Urol Nephrol Suppl; 1989; 118():1-64. PubMed ID: 2785286
[TBL] [Abstract][Full Text] [Related]
3. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?
Avbersek-Luznik I; Balon BP; Rus I; Marc J
Nephrol Dial Transplant; 2005 Mar; 20(3):566-70. PubMed ID: 15665031
[TBL] [Abstract][Full Text] [Related]
4. Association between Biomarkers of Mineral and Bone Metabolism and Removal of Calcium and Phosphate in Hemodialysis.
Debowska M; Dai L; Wojcik-Zaluska A; Poleszczuk J; Zaluska W; Lindholm B; Waniewski J
Blood Purif; 2020; 49(1-2):71-78. PubMed ID: 31726453
[TBL] [Abstract][Full Text] [Related]
5. Two-site immunoradiometric intact parathyroid hormone assay versus C-terminal parathyroid hormone in predicting osteodystrophic bone lesions in predialysis chronic renal failure.
Coen G; Mazzaferro S; Ballanti P; Bonucci E; Cinotti GA; Fondi G; Manni M; Pasquali M; Perruzza I; Sardella D
J Lab Clin Med; 1993 Jul; 122(1):103-9. PubMed ID: 8320484
[TBL] [Abstract][Full Text] [Related]
6. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
7. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
Singh AK; Avula S; Kher V; Rao DS; Mithal A
Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone and large related C-terminal fragments increase at different rates with worsening of renal function in chronic kidney disease patients. A possible indicator of bone turnover status?
Donadio C; Ardini M; Lucchesi A; Donadio E; Cantor T
Clin Nephrol; 2007 Mar; 67(3):131-9. PubMed ID: 17390737
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA
Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657
[TBL] [Abstract][Full Text] [Related]
10. Skeletal responsiveness to endogenous parathyroid hormone in postmenopausal osteoporosis.
Ebeling PR; Jones JD; Burritt MF; Duerson CR; Lane AW; Hassager C; Kumar R; Riggs BL
J Clin Endocrinol Metab; 1992 Oct; 75(4):1033-8. PubMed ID: 1400868
[TBL] [Abstract][Full Text] [Related]
11. Effect of glycemic control on calcium and phosphorus handling and parathyroid hormone level in patients with non-insulin-dependent diabetes mellitus.
Nagasaka S; Murakami T; Uchikawa T; Ishikawa SE; Saito T
Endocr J; 1995 Jun; 42(3):377-83. PubMed ID: 7670567
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactive parathyroid hormone and calcitonin in plasma and ultrafiltrate before and after haemodialysis.
Fauchald P; Gautvik VT; Gautvik KM
Scand J Clin Lab Invest; 1985 May; 45(3):229-35. PubMed ID: 4001828
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure].
Ziółkowska H; Roszkowska-Blaim M
Przegl Lek; 2006; 63 Suppl 3():149-52. PubMed ID: 16898516
[TBL] [Abstract][Full Text] [Related]
14. Acute effect of oral, intraperitoneal, and intravenous 1 alpha-hydroxycholecalciferol on markers of bone metabolism.
Joffe P; Ladefoged SD; Cintin C; Jensen LT; Hyldstrup L
Nephrol Dial Transplant; 1994; 9(5):524-31. PubMed ID: 8090332
[TBL] [Abstract][Full Text] [Related]
15. Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.
Inaba M; Okuno S; Imanishi Y; Ueda M; Yamakawa T; Ishimura E; Nishizawa Y
Osteoporos Int; 2005 May; 16(5):517-25. PubMed ID: 15322741
[TBL] [Abstract][Full Text] [Related]
16. Secretion of parathyroid hormone oscillates depending on the change in serum ionized calcium during hemodialysis and may affect bone metabolism.
Kitahara T; Ueki K; Kuroiwa T; Kaneko Y; Hiromura K; Nojima Y
Nephron Clin Pract; 2005; 101(1):c9-17. PubMed ID: 15886497
[TBL] [Abstract][Full Text] [Related]
17. Acute suppression of parathyroid activity during hemofiltration.
Panichi V; Bianchi AM; Andreini B; Casarosa L; Migliori M; De Pietro S; Ferdeghini M; Palla R
Blood Purif; 1996; 14(1):15-9. PubMed ID: 8718560
[TBL] [Abstract][Full Text] [Related]
18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
[TBL] [Abstract][Full Text] [Related]
20. Hemofiltration or hemodiafiltration with on-line production of substitution fluid: clinical observation of safety and effectiveness.
Li X; Li M; Liu T; Li L; Duan L; Li Y; Yang G; Guo L
Chin Med J (Engl); 1997 Jul; 110(7):520-5. PubMed ID: 9594209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
